• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向易休眠乳腺癌细胞中对PIK3C3-mTORC1信号通路的依赖性可抑制转移起始。

Targeting the Dependence on PIK3C3-mTORC1 Signaling in Dormancy-Prone Breast Cancer Cells Blunts Metastasis Initiation.

作者信息

Elkholi Islam E, Robert Amélie, Malouf Camille, Wu Joshua L, Kuasne Hellen, Drapela Stanislav, Macleod Graham, Hébert Steven, Pacis Alain, Calderon Virginie, Kleinman Claudia L, Gomes Ana P, Alvarez James V, Aguirre-Ghiso Julio A, Park Morag, Angers Stéphane, Côté Jean-François

机构信息

Montreal Clinical Research Institute, Montreal, Canada.

Molecular Biology Programs, Université de Montréal, Montreal, Canada.

出版信息

Cancer Res. 2025 Jun 16;85(12):2179-2198. doi: 10.1158/0008-5472.CAN-23-2654.

DOI:10.1158/0008-5472.CAN-23-2654
PMID:
40372253
Abstract

UNLABELLED

Halting breast cancer metastatic relapse following primary tumor removal remains challenging due to a lack of specific vulnerabilities to target during the clinical dormancy phase. To identify such vulnerabilities, we conducted genome-wide CRISPR screens on two breast cancer cell lines with distinct dormancy properties: 4T1 (short-term dormancy) and 4T07 (prolonged dormancy). The dormancy-prone 4T07 cells displayed a unique dependency on class III PI3K (PIK3C3). Unexpectedly, 4T07 cells exhibited higher mechanistic target of rapamycin complex 1 (mTORC1) activity than 4T1 cells due to lysosome-dependent signaling occurring at the cell periphery. Pharmacologic inhibition of PIK3C3 suppressed this phenotype in the 4T1-4T07 models as well as in human breast cancer cell lines and a breast cancer patient-derived xenograft. Furthermore, inhibiting PIK3C3 selectively reduced metastasis burden in the 4T07 model and eliminated dormant cells in a HER2-dependent murine breast cancer dormancy model. These findings suggest that PIK3C3-peripheral lysosomal signaling to mTORC1 may represent a targetable axis for preventing dormant cancer cell-initiated metastasis in patients with breast cancer.

SIGNIFICANCE

Dormancy-prone breast cancer cells depend on the class III PI3K to mediate peripheral lysosomal positioning and mTORC1 hyperactivity, which can be targeted to blunt breast cancer metastasis.

摘要

未标记

由于在临床休眠期缺乏可靶向的特定脆弱点,在原发性肿瘤切除后阻止乳腺癌转移复发仍然具有挑战性。为了确定此类脆弱点,我们对两种具有不同休眠特性的乳腺癌细胞系进行了全基因组CRISPR筛选:4T1(短期休眠)和4T07(长期休眠)。易于进入休眠状态的4T07细胞对III类PI3K(PIK3C3)表现出独特的依赖性。出乎意料的是,由于细胞外周发生的溶酶体依赖性信号传导,4T07细胞表现出比4T1细胞更高的雷帕霉素复合物1(mTORC1)活性。PIK3C3的药理学抑制在4T1-4T07模型以及人乳腺癌细胞系和乳腺癌患者来源的异种移植中抑制了这种表型。此外,抑制PIK3C3在4T07模型中选择性降低转移负担,并在HER2依赖性小鼠乳腺癌休眠模型中消除休眠细胞。这些发现表明,PIK3C3-外周溶酶体向mTORC1的信号传导可能代表了预防乳腺癌患者中休眠癌细胞引发转移的一个可靶向轴。

意义

易于进入休眠状态的乳腺癌细胞依赖III类PI3K来介导外周溶酶体定位和mTORC1过度活跃,这可以作为靶点来抑制乳腺癌转移。

相似文献

1
Targeting the Dependence on PIK3C3-mTORC1 Signaling in Dormancy-Prone Breast Cancer Cells Blunts Metastasis Initiation.靶向易休眠乳腺癌细胞中对PIK3C3-mTORC1信号通路的依赖性可抑制转移起始。
Cancer Res. 2025 Jun 16;85(12):2179-2198. doi: 10.1158/0008-5472.CAN-23-2654.
2
Targeting the dependence on PIK3C3-mTORC1 signaling in dormancy-prone breast cancer cells blunts metastasis initiation.针对易休眠乳腺癌细胞中对PIK3C3-mTORC1信号通路的依赖性,可抑制转移起始。
bioRxiv. 2024 Aug 8:2023.08.02.551681. doi: 10.1101/2023.08.02.551681.
3
Cre/loxP approach-mediated downregulation of Pik3c3 inhibits the hypertrophic growth of renal proximal tubule cells.Cre/loxP 途径介导的 Pik3c3 下调抑制肾近端小管细胞的肥大生长。
J Cell Physiol. 2020 Dec;235(12):9958-9973. doi: 10.1002/jcp.29811. Epub 2020 May 31.
4
PtdIns3P controls mTORC1 signaling through lysosomal positioning.磷脂酰肌醇-3-磷酸(PtdIns3P)通过溶酶体定位来控制雷帕霉素靶蛋白复合体1(mTORC1)信号传导。
J Cell Biol. 2017 Dec 4;216(12):4217-4233. doi: 10.1083/jcb.201611073. Epub 2017 Oct 13.
5
The expression level of class III phosphatidylinositol-3 kinase controls the degree of compensatory nephron hypertrophy.III 类磷酸肌醇-3 激酶的表达水平控制代偿性肾单位肥大的程度。
Am J Physiol Renal Physiol. 2020 Mar 1;318(3):F628-F638. doi: 10.1152/ajprenal.00381.2019. Epub 2020 Jan 6.
6
In Vivo Evidence for Serine Biosynthesis-Defined Sensitivity of Lung Metastasis, but Not of Primary Breast Tumors, to mTORC1 Inhibition.体内证据表明丝氨酸生物合成定义了肺转移对 mTORC1 抑制的敏感性,但对原发性乳腺肿瘤没有影响。
Mol Cell. 2021 Jan 21;81(2):386-397.e7. doi: 10.1016/j.molcel.2020.11.027. Epub 2020 Dec 18.
7
Targeting PI3K inhibitor resistance in breast cancer with metabolic drugs.用代谢药物靶向治疗乳腺癌中的PI3K抑制剂耐药性。
Signal Transduct Target Ther. 2025 Mar 21;10(1):92. doi: 10.1038/s41392-025-02180-4.
8
Molecular regulation of apoptotic machinery and lipid metabolism by mTORC1/mTORC2 dual inhibitors in preclinical models of HER2+/PIK3CAmut breast cancer.在HER2+/PIK3CA突变乳腺癌临床前模型中,mTORC1/mTORC2双重抑制剂对凋亡机制和脂质代谢的分子调控
Oncotarget. 2016 Oct 11;7(41):67071-67086. doi: 10.18632/oncotarget.11490.
9
Morin overcomes doxorubicin resistance in human breast cancer by inducing DNA damage and modulating the LKB1/AMPK/mTORC1 signaling pathway.桑色素通过诱导DNA损伤和调节LKB1/AMPK/mTORC1信号通路克服人乳腺癌中的阿霉素耐药性。
Biofactors. 2025 Jan-Feb;51(1):e2112. doi: 10.1002/biof.2112. Epub 2024 Aug 8.
10
DIF-1 inhibits growth and metastasis of triple-negative breast cancer through AMPK-mediated inhibition of the mTORC1-S6K signaling pathway.DIF-1 通过 AMPK 介导的抑制 mTORC1-S6K 信号通路抑制三阴性乳腺癌的生长和转移。
Oncogene. 2021 Sep;40(37):5579-5589. doi: 10.1038/s41388-021-01958-4. Epub 2021 Jul 24.

引用本文的文献

1
Bridging the Gap in Breast Cancer Dormancy: Models, Mechanisms, and Translational Challenges.弥合乳腺癌休眠的差距:模型、机制及转化挑战
Pharmaceuticals (Basel). 2025 Jun 26;18(7):961. doi: 10.3390/ph18070961.

本文引用的文献

1
Autophagy is required for mammary tumor recurrence by promoting dormant tumor cell survival following therapy.自噬通过促进治疗后休眠肿瘤细胞的存活而促进乳腺肿瘤的复发。
Breast Cancer Res. 2024 Oct 18;26(1):143. doi: 10.1186/s13058-024-01878-7.
2
How can we integrate the biology of breast cancer cell dormancy into clinical practice?我们如何将乳腺癌细胞休眠的生物学特性融入临床实践?
Cancer Cell. 2024 Jul 8;42(7):1147-1151. doi: 10.1016/j.ccell.2024.05.023. Epub 2024 Jun 20.
3
Breast Cancer Metastatic Dormancy and Relapse: An Enigma of Microenvironment(s).
乳腺癌转移休眠与复发:微环境之谜。
Cancer Res. 2022 Dec 16;82(24):4497-4510. doi: 10.1158/0008-5472.CAN-22-1902.
4
Bone marrow NG2/Nestin mesenchymal stem cells drive DTC dormancy TGFβ2.骨髓NG2/巢蛋白间充质干细胞通过转化生长因子β2驱动甲状腺微小癌休眠。
Nat Cancer. 2021 Mar;2(3):327-339. doi: 10.1038/s43018-021-00179-8. Epub 2021 Mar 11.
5
Cellular dormancy in minimal residual disease following targeted therapy.靶向治疗后微小残留病灶中的细胞休眠。
Breast Cancer Res. 2021 Jun 4;23(1):63. doi: 10.1186/s13058-021-01416-9.
6
The PI3K/mTOR inhibitor Gedatolisib eliminates dormant breast cancer cells in organotypic culture, but fails to prevent metastasis in preclinical settings.PI3K/mTOR 抑制剂 Gedatolisib 可消除器官培养中的休眠乳腺癌细胞,但未能预防临床前环境中的转移。
Mol Oncol. 2022 Jan;16(1):130-147. doi: 10.1002/1878-0261.13031. Epub 2021 Jun 25.
7
The current paradigm and challenges ahead for the dormancy of disseminated tumor cells.播散肿瘤细胞休眠的当前范式和面临的挑战。
Nat Cancer. 2020 Jul;1(7):672-680. doi: 10.1038/s43018-020-0088-5. Epub 2020 Jul 6.
8
CD39PD-1CD8 T cells mediate metastatic dormancy in breast cancer.CD39+PD-1+CD8 T 细胞介导乳腺癌转移休眠。
Nat Commun. 2021 Feb 3;12(1):769. doi: 10.1038/s41467-021-21045-2.
9
Multi-Omics Characterization of the 4T1 Murine Mammary Gland Tumor Model.4T1小鼠乳腺肿瘤模型的多组学特征分析
Front Oncol. 2020 Jul 23;10:1195. doi: 10.3389/fonc.2020.01195. eCollection 2020.
10
NRF2 activation promotes the recurrence of dormant tumour cells through regulation of redox and nucleotide metabolism.NRF2 激活通过调节氧化还原和核苷酸代谢促进休眠肿瘤细胞的复发。
Nat Metab. 2020 Apr;2(4):318-334. doi: 10.1038/s42255-020-0191-z. Epub 2020 Apr 20.